Tandem Diabetes Care (TNDM) Current Assets (2016 - 2025)
Historic Current Assets for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $616.9 million.
- Tandem Diabetes Care's Current Assets fell 1804.96% to $616.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $616.9 million, marking a year-over-year decrease of 1804.96%. This contributed to the annual value of $724.5 million for FY2024, which is 314.15% down from last year.
- Per Tandem Diabetes Care's latest filing, its Current Assets stood at $616.9 million for Q3 2025, which was down 1804.96% from $614.8 million recorded in Q2 2025.
- Over the past 5 years, Tandem Diabetes Care's Current Assets peaked at $850.0 million during Q4 2022, and registered a low of $614.8 million during Q2 2025.
- For the 5-year period, Tandem Diabetes Care's Current Assets averaged around $743.9 million, with its median value being $752.8 million (2024).
- As far as peak fluctuations go, Tandem Diabetes Care's Current Assets surged by 13558.55% in 2021, and later plummeted by 1804.96% in 2025.
- Over the past 5 years, Tandem Diabetes Care's Current Assets (Quarter) stood at $811.5 million in 2021, then grew by 4.74% to $850.0 million in 2022, then fell by 12.0% to $748.0 million in 2023, then decreased by 3.14% to $724.5 million in 2024, then decreased by 14.84% to $616.9 million in 2025.
- Its Current Assets stands at $616.9 million for Q3 2025, versus $614.8 million for Q2 2025 and $663.4 million for Q1 2025.